Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Teva Pharmaceutical Industries ADR
(NY:
TEVA
)
14.06
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, May 6, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Teva Pharmaceutical Industries ADR
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
15
16
Next >
Will Bed Bath & Beyond (BBBY) Stock Really Fall to $1?
July 12, 2022
Bed Bath & Beyond (BBBY) stock is in the news today after an incredibly bearish analyst said the retailer's shares will fall to $1 a piece.
Via
InvestorPlace
What Is Going on With Teva Pharmaceuticals (TEVA) Stock Today?
July 12, 2022
TEVA stock, already trading far below its prior peak, may come under pressure in the near future due to the threat of ongoing litigation.
Via
InvestorPlace
New York Attorney General Says Teva Tried To Evade Accountability On Opioid Crisis: Report
July 12, 2022
Reuters reported that New York's attorney general said Teva Pharmaceutical Industries Ltd (NY
Via
Benzinga
Analyst Ratings for Teva Pharmaceutical Indus
June 14, 2022
Within the last quarter, Teva Pharmaceutical Indus (NYSE:TEVA) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2022
June 14, 2022
Upgrades
Via
Benzinga
Why Generic Drugs Giant Teva Pharmaceutical Just Cut Its 2022 Outlook
May 03, 2022
Foreign exchange rates are weighing heavily on sales, according to the firm's CEO.
Via
Investor's Business Daily
Golden Cross Appears Before Teva Pharmaceutical Indus Investors
May 27, 2022
If history is any guide, there may be good fortune ahead for shares of Teva Pharmaceutical Indus (NYSE:TEVA). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be...
Via
Benzinga
Teva, Allergan Settle Opioid Lawsuit With West Virginia
May 25, 2022
U.S. affiliate of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) has reached an agreement with the Attorney General of West Virginia that settles the state's opioid-related claims.
Via
Benzinga
Teva Pharmaceutical Shares Real-World Data Of ProAir Digihaler In Asthma Patients
May 17, 2022
Via
Benzinga
BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal
May 17, 2022
Prospects of a global opioid deal getting done in 2022 suggest a “potential path to upside” for Teva Pharmaceutical Industries Ltd.’s (NYSE: TEVA) stock, according to BofA Securities.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2022
May 17, 2022
Via
Benzinga
FDA Rejects Teva - MedinCell's Schizophrenia Candidate
April 20, 2022
Via
Benzinga
4 Analysts Have This to Say About Teva Pharmaceutical Indus
May 12, 2022
Over the past 3 months, 4 analysts have published their opinion on Teva Pharmaceutical Indus (NYSE:TEVA) stock. These analysts are typically employed by large Wall Street banks and tasked with...
Via
Benzinga
Teva, Allergan Ready To Pay $5B To Settle Lawsuits Related To Opioid Painkillers: Bloomberg
May 11, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2022
May 04, 2022
Upgrades
Via
Benzinga
Teva Posts Mixed Q1 Earnings, Cuts FY22 Sales Guidance Citing Copaxone Competition, Yet Shares Rise
May 03, 2022
Via
Benzinga
The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
May 03, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
Recap: Teva Pharmaceutical Q1 Earnings
May 03, 2022
Teva Pharmaceutical Indus (NYSE:TEVA) reported its Q1 earnings results on Tuesday, May 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
May 02, 2022
Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks...
Via
Benzinga
Earnings Scheduled For May 3, 2022
May 03, 2022
Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.
Via
Benzinga
San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters
April 25, 2022
Via
Benzinga
JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters
April 20, 2022
Via
Benzinga
The Daily Biotech Pulse: Windtree Jumps On Istaroxime Data, Arcturus' COVID-19 Vaccine Trial Data, FDA Rejects Teva's Schizophrenia Med, Otonomy Aces Hearing Loss Study
April 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours.
Via
Benzinga
What Were Your Best And Worst Stock Buys? What Does The Zinger Nation Think?
April 06, 2022
Admitting to success is a lot easier than failure and when it comes to stocks, not only is there money involved, but also questioning your — or your advisor's — judgment. And then there is the advice...
Via
Benzinga
Good and Bad stock news
April 05, 2022
Microsoft is down because of an FTC investigation of its possible anti-competitive moves.
Via
Talk Markets
Futures Slide To Overnight Lows As Algos Spooked By EU Ban On Russian Coal
April 05, 2022
After initially trading sharply higher around the European open, US stock futures dropped to session lows as traders digested the latest developments in the Ukraine war.
Via
Talk Markets
West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters
April 04, 2022
West Virginia's attorney general urged a judge to hold Johnson & Johnson (NYSE: JNJ), Teva Pharmaceuticals Industries Ltd (NYSE: TEVA), and AbbVie Inc's (NYSE:
Via
Benzinga
CVS Health, Teva Settle Florida State's Opioid-Related Claims: Report
March 30, 2022
Florida has reached more than $878 million in settlements with CVS Health Corp (NYSE: CVS) and three drug companies to resolve claims and avert a trial next month over their roles in fueling an opioid...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 5, 2022
April 05, 2022
Upgrades
Via
Benzinga
Monday Markets News
March 28, 2022
Japanese Takeda TAK shares failed to thrive after its edema prevention drug was approved.
Via
Talk Markets
< Previous
1
2
...
5
6
7
8
9
10
11
12
13
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.